| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/02/2008 | CN100398110C Preparation containing ultra-low-doses of estrogen, patch and reagent box |
| 07/02/2008 | CN100398108C Nasal cavity nebula containing scopolamine hydrobromide |
| 07/02/2008 | CN100398100C Method for extracting high-content solanesol extract by liquid-liquid two-phase method |
| 07/02/2008 | CN100398099C Stomachache easing dripping pills with celandine as raw materials and its preparation process |
| 07/02/2008 | CN100398098C Ganoderma astragalus drip pill for treating heart spleen vacuity |
| 07/02/2008 | CN100398097C Siji sanhuang new preparation and preparing method and application |
| 07/02/2008 | CN100398096C Spherical particles of taurine, and preparation method |
| 07/02/2008 | CN100398095C Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation |
| 07/02/2008 | CN100398094C Formoterol superfine formulation |
| 07/02/2008 | CN100398093C Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 07/02/2008 | CN100398090C Quaternary compounds comprising propolis as the active substance |
| 07/02/2008 | CN100398010C Donkey-hide gelatine paste and its preparing method |
| 07/01/2008 | US7395111 Transdermal delivery system for water insoluble drugs |
| 07/01/2008 | US7393951 antisense to a nucleotide sequence of positions 47 to 51 of 7SL RNA of the signal recognition particle (SRP); inhibitor of cancer cell growth |
| 07/01/2008 | US7393928 Recombinant gelatins |
| 07/01/2008 | US7393909 Porous, molecularly imprinted polymer and a process for the preparation thereof |
| 07/01/2008 | US7393841 for improved microcirculation, cryo-conservation of blood components such as erythrocytes of granulocytes, and as sedimentation aid in cell separation in connection with leucapheresis |
| 07/01/2008 | US7393840 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 07/01/2008 | US7393828 to be used in pharmaceutical delivery vehicles for controlled and/or localized release of therapeutic molecules (e.g., small molecules, peptides, proteins or other macromolecules). |
| 07/01/2008 | US7393630 Immunological adjuvants and antigen entrapment; combining a submicron oil-in-water emulsion with a selected antigen entrapped in, or adsorbed to, a biodegradable microparticle, wherein the microparticle is formed from a poly(L-lactide), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) |
| 07/01/2008 | US7393548 Mean droplet size below one micron; emulsifying stabilizer such as cetearyl glucoside, sucrose esters or sorbitan esters; cosmetic or pharmaceutical agent |
| 07/01/2008 | US7393547 Antimicrobial elastomer composition and method for making |
| 07/01/2008 | US7393545 Lipstatin derivative—soluble fiber tablets |
| 07/01/2008 | US7393544 Microstructures containing a drug and a suspension medium that permeates into the permeable microstructures; density variations between suspended particles and medium are minimized and attractive forces between microstructures are attenuated, resulting in settling and flocculation resistance |
| 07/01/2008 | US7393543 Vaginally administratable progesterone-containing tablets and method for preparing same |
| 07/01/2008 | US7393541 Mycobacterial vaccine |
| 07/01/2008 | US7393535 Adjuvants for use in vaccines |
| 07/01/2008 | US7393522 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 07/01/2008 | US7393519 Base for oral composition and the oral composition |
| 07/01/2008 | US7393478 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 07/01/2008 | US7393259 Method of forming emitters and method of manufacturing field emission device (FED) |
| 06/26/2008 | WO2008077110A2 Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 06/26/2008 | WO2008077108A1 Ophthalmic and contact lens solutions with a peroxide source and a preservative |
| 06/26/2008 | WO2008077106A1 L-histidine in ophthalmic solutions |
| 06/26/2008 | WO2008076819A2 Human growth hormone formulations |
| 06/26/2008 | WO2008076780A2 Amorphous valsartan and the production thereof |
| 06/26/2008 | WO2008076604A1 Bone growth particles and osteoinductive composition thereof |
| 06/26/2008 | WO2008076436A2 Systems and methods for a pregnancy monitoring device |
| 06/26/2008 | WO2008076373A1 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| 06/26/2008 | WO2008076333A2 Polymer-drug conjugates with tether groups for controlled drug delivery |
| 06/26/2008 | WO2008076287A2 Methods of making pharmaceutical components for customized drug products |
| 06/26/2008 | WO2008076261A2 Water-soluble phenicol prodrugs in a lipophilic vehicle system |
| 06/26/2008 | WO2008075984A2 Tablet formulation including macrocyclic lactone and levamisole anthelmintic agents |
| 06/26/2008 | WO2008075862A1 A method for preparing materials having antithrombotic activity from muskrat musk and materials obtained from the method |
| 06/26/2008 | WO2008075762A1 Sustained-release composition and method for producing the same |
| 06/26/2008 | WO2008075706A1 Therapeutic agent for interstitial pneumonia |
| 06/26/2008 | WO2008075665A1 Transdermally absorbable preparation and adhesive sheet for application to the skin |
| 06/26/2008 | WO2008075522A1 Radioactive diagnostic imaging agent |
| 06/26/2008 | WO2008075448A1 Chitosan solution and medical preparation with chitosan coating formed from the solution |
| 06/26/2008 | WO2008075372A1 Controlled release dosage forms of zolpidem |
| 06/26/2008 | WO2008075333A2 Edible compositions for preventing hair loss |
| 06/26/2008 | WO2008075330A1 Method for administration of pegylated liposomal doxorubicin |
| 06/26/2008 | WO2008075321A2 Modified-release formulations of azabicyclo derivatives |
| 06/26/2008 | WO2008075320A2 Antilipidemic pharmaceutical compositions and process for preparation thereof |
| 06/26/2008 | WO2008075234A1 Skin care delivery device having a releasable backing |
| 06/26/2008 | WO2008075206A2 Cell-matrix microspheres, methods for preparation and applications |
| 06/26/2008 | WO2008075102A1 Pharmaceutical compositions for transmucusal delivery of a therapeutically active agent on the basis of submicron particles |
| 06/26/2008 | WO2008074885A2 Process for manufacturing ophthalmic oil-in-water emulsions |
| 06/26/2008 | WO2008074871A1 Dispersion of polyamino acids in a continuous lipid phase |
| 06/26/2008 | WO2008074860A1 Pharmaceutical composition comprising nicotinamide or nicotinic acid |
| 06/26/2008 | WO2008074856A1 Combination therapy for the treatment of airways disease |
| 06/26/2008 | WO2008074853A1 Ophthalmic rebamipide solution |
| 06/26/2008 | WO2008074804A2 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application |
| 06/26/2008 | WO2008074784A1 Process for providing a quantity of a particulate material, product and apparatus |
| 06/26/2008 | WO2008074573A1 Topical dosage form comprising tri-substituted glycerol compounds |
| 06/26/2008 | WO2008074479A1 Gelatin capsules comprising an acid |
| 06/26/2008 | WO2008074419A1 Dosage form comprising immediate release naproxen and sustained release opioid analgesic |
| 06/26/2008 | WO2008074267A2 Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing |
| 06/26/2008 | WO2008074154A1 Polymers comprising zwitterionic endgroups |
| 06/26/2008 | WO2008074145A1 Pharmaceutical composition comprising a hot-melt granulated lubricant |
| 06/26/2008 | WO2008074144A1 A composition containing a bisphosphonic acid in combination with vitamin d |
| 06/26/2008 | WO2008074108A2 Controlled release pharmaceutical composition of anti-hyperglycemic agent and its preparation |
| 06/26/2008 | WO2008074098A1 Pharmaceutical composition |
| 06/26/2008 | WO2008074097A1 Pharmaceutical compound and composition |
| 06/26/2008 | WO2008058234A3 Pharmaceutical formulations for 1,4-dihyrdropyridine compounds having improved solubility |
| 06/26/2008 | WO2008051617A9 Dry granulated pharmaceutical compositions and methods for producing same |
| 06/26/2008 | WO2008047201A3 Solid dispersion comprising a poorly water soluble drug |
| 06/26/2008 | WO2008044236A3 Improved release of statins in the intestine |
| 06/26/2008 | WO2008041514A9 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 06/26/2008 | WO2008038241A3 Electrically activated gel array for transdermal drug delivery |
| 06/26/2008 | WO2008038003A3 Pharmaceutical compositions of aripiprazole |
| 06/26/2008 | WO2008037359A3 Active ingredient containing stabilised solid medicinal forms and method for the production thereof |
| 06/26/2008 | WO2008035246A3 Compositions containing quaternary ammonium compounds |
| 06/26/2008 | WO2008031780A3 Method for producing fine-particle dispersions |
| 06/26/2008 | WO2008030557A9 Compositions and methods for enhancing transport through mucus |
| 06/26/2008 | WO2008013938A3 Aerosolizable formulation comprising insulin for pulmonary delivery |
| 06/26/2008 | WO2008011154A3 Formulations for benzimidazolyl pyridyl ethers |
| 06/26/2008 | WO2008007290A3 Core-shell nanoparticles for thearapy and imaging purposes |
| 06/26/2008 | WO2008005353A3 Immediate-release tablet formulations of a thrombin receptor antagonist |
| 06/26/2008 | WO2008003769A3 An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof |
| 06/26/2008 | WO2008001140A3 Pellet formulation comprising colloidal silicon dioxide |
| 06/26/2008 | WO2008000780A3 Inhalant powder containing phenylalanine |
| 06/26/2008 | WO2007135523A3 A composition for inactivating an enveloped virus |
| 06/26/2008 | WO2007135193A3 Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means |
| 06/26/2008 | WO2007119177A3 Modified release formulations and methods of treating inflammatory bowel disease |
| 06/26/2008 | WO2007106284A3 Silicone based emulsions for topical drug delivery |
| 06/26/2008 | WO2007070840A8 Modified and pulsatile release pharmaceutical formulations of escitalopram |
| 06/26/2008 | WO2007062206A3 Chocolate formulations with functional properties |
| 06/26/2008 | US20080154250 Devices, Systems and Methods For Diagnosing and Treating Sinusitis and Other Disorders of the Ears, Nose and/or Throat |
| 06/26/2008 | US20080154243 Delivery device for a fluid |